Component

Human PNPO IVS3-1G>A splice genotype

Historical splice-site designation from Mills 2005; c.364-1G>A in subsequent nomenclature.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. The human PNPO IVS3-1G>A splice-site construct had no detectable PNPO activity in the reported CHO expression assay.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    evidence_location
    Indexed abstract: CHO expression studies
    experimental_model
    Five affected patients and human PNPO constructs expressed in CHO cells.
    exposure
    Construct expression, not nutrient withdrawal.
    limitations
    Cannot generalize to every PNPO variant or vitamer treatment response.
    nutrient_topic
    Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
    organism
    Homo sapiens protein expressed in Cricetulus griseus cells
    plain_language
    This variant prevented measured B6 activation.
    primary_references
    [mills2005] Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase. (2005). https://pubmed.ncbi.nlm.nih.gov/15772097/ DOI: 10.1093/hmg/ddi120
    tissue_or_cell_type
    CHO expression system
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 361–372

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Five affected patients and human PNPO constructs expressed in CHO cells. · source_derived_draft · unverified_draft

    ### b6-transport-pnpo-splice The human PNPO IVS3-1G>A splice-site construct had no detectable PNPO activity in the reported CHO expression assay. Condition category: machinery_impairment nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: This variant prevented measured B6 activation. organism: Homo sapiens protein expressed in Cricetulus griseus cells tissue_or_cell_type: CHO expression system experimental_model: Five affected patients and human PNPO constructs expressed in CHO cells. limitations: Cannot generalize to every PNPO variant or vitamer treatment response. exposure: Construct expression, not nutrient withdrawal. evidence_location: Indexed abstract: CHO expression studies [mills2005] Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase. (2005). https://pubmed.ncbi.nlm.nih.gov/15772097/ DOI: 10.1093/hmg/ddi120
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards